A fluorescence polarization immunoassay (FPI) 
. The need for universal testing in patients receiving this antibiotic is yet unproven. However, although teicoplanin is reportedly less nephrotoxic than vancomycin, at least within certain subpopulations with serious infections, individual variation in pharmacokinetic parameters will require that monitoring of levels in serum, within the range of 5 to 150 mg/liter, for both efficacy and toxicity will be advisable (6) .
Bioassay is established as an accurate method of estimation of teicoplanin levels (2, 4) increasing value being measured, the linear regressions were performed by using a logarithmic scale. Results obtained from patients samples by both FPI and bioassay were also analyzed on a logarithmic scale by using an errors-invariables regression model to allow for method error in both assay systems (3) . All calculations were performed by using the SAS Statistical Package (7).
RESULTS
Prepared (spiked) serum samples. Comparison of values obtained by FPI in the 54 samples in which teicoplanin was added with theoretical concentrations is illustrated in Table  1 . By using least-squares linear regression on a logarithmic scale, the equation of the regression line for FPI was y = 1.14x°-952, with a correlation coefficient of 0.999. The coefficient of variation at each concentration was equal to or less than 4.3%.
Comparison with bioassay. Sixty-three samples containing teicoplanin only were assayed by FPI and bioassay. Figure 1 illustrates the degree of agreement between the two methods. An errors-in-variables model on a logarithmic scale was used to analyze the correlation between techniques and yielded an equation ofy = 0.09x°84, wherey is FPI andx is the bioassay parameter. A correlation coefficient of 0.909 was established.
Precision. Intraassay and interassay variabilities were determined by using supplied standards (controls) of three different concentrations (approximately 75, 35, and 7 mg/ liter). These assays were undertaken on each occasion that the calibration curve was confirmed and on each day that patient samples were assayed. Results are presented in Table 2 . These data were assessed by linear regression by using the method of least squares on a logarithmic scale and yielded an equation of y = 1.21xl 21, with a correlation coefficient of 0.993. Intraassay variation was small, being between 0.7 and 7.3%, while interassay variability was slightly greater, at 8.6 to 11.6%. Specificity. Results for samples containing teicoplanin and gentamicin are illustrated in Fig. 2 . By using an errors-invariables method of linear regression on a logarithmic scale, The Innotron FPI with the Abbott TDx instrument can be described as sensitive and precise; it uses technology familiar to workers in many routine diagnostic laboratories and has advantages over bioassay in terms of turnaround time and specificity. It should prove to be a useful method of measuring teicoplanin. 
